JnJ to stop manufacturing its talc based baby powder from 2023 Roshni Dhar13 Aug 2022 5:51 PM ISTJohnson & Johnson will stop selling talc-based baby powder globally in 2023, the drug maker said on Thursday, more than two years after it ended...
Health Bulletin 13/August/2022 Roshni Dhar13 Aug 2022 5:20 PM ISTHere are the top health stories for the day:With strict bond terms, Rajasthan in-service PG medicos facing trouble getting study leaveWith the State...
Mired in controversy, JNJ baby powder to go off shelves from 2023 Ruchika Sharma13 Aug 2022 2:00 PM ISTThe company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with...
Mathai Mammen leaves position as JnJ Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma12 Aug 2022 3:00 PM ISTNew Brunswick: Johnson & Johnson has announced that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice...
Janssen bags USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Rahul Verma6 Aug 2022 8:16 PM ISTThe Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the U.S. Food and Drug Administration (USFDA) has approved STELARA...
Janssen gets USFDA nod for psoriatic arthritis treatment STELARA for pediatric patients Ruchika Sharma4 Aug 2022 11:46 AM ISTSTELARA is administered as a subcutaneous injection dosed four times per year after two starter doses for the treatment of pediatric patients six...
Johnson and Johnson cancer drug sales help weather hit from stronger dollar Ruchika Sharma20 July 2022 2:00 PM ISTThe company said it was raising prices of some products like painkillers and mouthwash in response to inflation.
Janssen Pharma gets USFDA Breakthrough Therapy Designation for Multiple Myeloma treatment Talquetamab Ruchika Sharma30 Jun 2022 3:02 PM ISTTalquetamab is an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting both GPRC5D, a novel drug target, on multiple...
WHO gives nod to Biological E as additional production site for JnJ COVID vaccine Ruchika Sharma23 Jun 2022 4:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age...
'Golden time for India to emerge as innovator nation in biopharma sector' Ruchika Sharma23 Jun 2022 3:30 PM ISTWashington: Post COVID19, it's a golden time for India to emerge as an innovator nation in the biopharma sector, organiser of the annual India-US...
USFDA nod for use of Apple watch to track Parkinson's symptoms Ruchika Sharma14 Jun 2022 4:00 PM ISTUsing the Apple Watch, Rune Labs' StrivePD software platform will provide doctors a continuous stream of observations over long stretches, Pepin said.
Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
